Fulgent Genetics, Inc. (FLGT) Stock

Healthcare · Diagnostics & Research · Member of Other US Stocks

Fulgent Genetics, Inc. (FLGT) closed at USD 21.01 on 2026-10-14, a change of -10.3 % over the past year, with a market capitalization of USD 587.18M.

Fulgent Genetics, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Fulgent Genetics, Inc. key figures

Previous close

USD 21.01 (2026-10-14)

1-year change

-10.3 %

Market cap

USD 587.18M

Enterprise value

USD 334.11M

P/E ratio (trailing)

-7.57

P/E ratio (forward)

-15.46

EPS (trailing)

-2.82

EPS (forward)

-1.38

PEG ratio

n/a

Price to book

0.59

Revenue growth

4.4 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

6.68

Employees

1,315

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Fulgent Genetics, Inc.

Fulgent Genetics, Inc. provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, large corporations, and patients. Fulgent Genetics, Inc. was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. The company was founded in 2011 and is headquartered in El Monte, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Fulgent Genetics, Inc. and compare it with other stocks.